<DOC>
	<DOCNO>NCT02086838</DOCNO>
	<brief_summary>Evaluate effect iron supplementation use oral route comparison total dose infusion low molecular weight iron dextran iron deficiency anemia pregnancy .</brief_summary>
	<brief_title>Iron Supplementation Using Total Dose Infusion Oral Routes Treatment Iron Deficiency Anemia Pregnancy</brief_title>
	<detailed_description>Patients allocate two group 106 insure everyone chance participation , randomization guide table random number All woman recruit study give 100 mg mebendazole tablet twice daily 3 day de-worming 500 micro gram folic acid daily till end study The require dose individually adapt accord total iron deficit dependent patient 's body weight hemoglobin status Total iron dose ( mg ) = weight ( kg ) X hemoglobin deficit { target hemoglobin ( g/l ) - Actual hemoglobin ( g/l ) } X 0.24 + 500 mg The total iron dose need calculated formula round near multiple 100 Group I include pregnant woman take 60 mg elemental iron twice per day ( 120 mg/day ) use iron tablet ( Theragran Hematinic ) Â® Smith-Kline Beecham , Egypt affiliate co. Glaxo Smith-Kline , accord WHO guideline IDA control Group II include pregnant woman take elemental iron form low molecular weight dextran complex intravenously total dose infusion ( T.D.I ) use iron dextran ampule ( Cosmofer ) R Pharmacosmos Denmark ( Inspire Pharma Egypt ) Inclusion criterion - Maternal age 20-35 year old . - Singleton pregnancy 16 - 24 week - Iron deficiency anemia average hemoglobin range 7-9 g/dL onset study Exclusion criteris - Extremes reproductive age ( less 20 year old 35 year old ) . - Patients multiple pregnancy . - Anemia link iron deficiency . - Allergy iron derivative . - Any medical disorder like diabetes tuberculosis ( TB ) , viral hepatitis cirrhosis , cardiovascular disease , renal disease , autoimmune disease , suspect acute infection , cancer . - Those received parenteral iron treatment earlier within 3 month start study . - Any obstetric complicating factor like pregnancy induce hypertension ( PIH ) . - Patients history chronic blood loss .</detailed_description>
	<mesh_term>Anemia</mesh_term>
	<mesh_term>Anemia , Iron-Deficiency</mesh_term>
	<mesh_term>Deficiency Diseases</mesh_term>
	<mesh_term>Iron</mesh_term>
	<mesh_term>Iron-Dextran Complex</mesh_term>
	<mesh_term>Hematinics</mesh_term>
	<mesh_term>Dextrans</mesh_term>
	<criteria>Maternal age 2035 year old . Singleton pregnancy 16 24 week . Iron deficiency anemia average hemoglobin range 79 g % onset study . Extremes reproductive age ( less 20 year old 35 year old ) . Patients multiple pregnancy . Anemia link iron deficiency . Allergy iron derivative . Any medical disorder like diabetes tuberculosis ( TB ) , viral hepatitis cirrhosis , cardiovascular disease , renal disease , autoimmune disease , suspect acute infection , cancer . Those received parenteral iron treatment earlier within 3 month start study . Any obstetric complicating factor like pregnancy induce hypertension . Patients history chronic blood loss .</criteria>
	<gender>Female</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>35 Years</maximum_age>
	<verification_date>March 2015</verification_date>
	<keyword>Iron deficiency anemia</keyword>
	<keyword>Pregnancy</keyword>
	<keyword>Iron therapy</keyword>
</DOC>